Pzena Investment Management LLC Has $40.82 Million Stake in USANA Health Sciences, Inc. (NYSE:USNA)

Pzena Investment Management LLC decreased its position in USANA Health Sciences, Inc. (NYSE:USNA) by 3.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 761,615 shares of the company’s stock after selling 25,824 shares during the period. Pzena Investment Management LLC’s holdings in USANA Health Sciences were worth $40,823,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Pacer Advisors Inc. increased its stake in USANA Health Sciences by 75.7% in the fourth quarter. Pacer Advisors Inc. now owns 337,371 shares of the company’s stock valued at $18,083,000 after purchasing an additional 145,373 shares in the last quarter. Vanguard Group Inc. increased its stake in USANA Health Sciences by 2.5% in the third quarter. Vanguard Group Inc. now owns 1,567,182 shares of the company’s stock valued at $91,853,000 after purchasing an additional 38,533 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in USANA Health Sciences by 3.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 677,664 shares of the company’s stock valued at $36,323,000 after purchasing an additional 21,524 shares in the last quarter. Cornercap Investment Counsel Inc. bought a new stake in USANA Health Sciences in the fourth quarter valued at $563,000. Finally, Hsbc Holdings PLC bought a new stake in USANA Health Sciences in the third quarter valued at $570,000. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Price Performance

Shares of NYSE:USNA traded up $0.13 during midday trading on Thursday, hitting $48.69. 8,182 shares of the company’s stock were exchanged, compared to its average volume of 79,167. The stock has a 50 day moving average price of $46.33 and a 200-day moving average price of $48.09. The company has a market cap of $927.54 million, a PE ratio of 15.13, a price-to-earnings-growth ratio of 1.49 and a beta of 0.94. USANA Health Sciences, Inc. has a 12 month low of $41.45 and a 12 month high of $69.60.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, April 30th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.69 by $0.17. The company had revenue of $227.80 million during the quarter, compared to the consensus estimate of $223.27 million. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. On average, analysts anticipate that USANA Health Sciences, Inc. will post 2.78 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, DA Davidson decreased their price target on shares of USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating for the company in a research note on Tuesday, May 7th.

Insiders Place Their Bets

In other USANA Health Sciences news, insider Daniel A. Macuga sold 3,791 shares of the company’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total value of $178,707.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other USANA Health Sciences news, insider Daniel A. Macuga sold 3,791 shares of the company’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total value of $178,707.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO G Doug Iiekking sold 5,198 shares of the business’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total transaction of $232,662.48. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,286 shares of company stock valued at $1,634,010. Corporate insiders own 0.33% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.